These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5610757)

  • 21. [Biometric analysis of results in experiments].
    BAITSCH H
    Z Klin Med; 1956; 154(2):184-6. PubMed ID: 13393182
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the use of vasoactive drugs].
    Cortinovis A; Cortinovis R; Pellegrino L
    Chir Patol Sper; 1968; ():Suppl 5:156+. PubMed ID: 5743361
    [No Abstract]   [Full Text] [Related]  

  • 23. [Critique on the use of the intra-arterial route for drug administration in arterial diseases of the lower extremities].
    TRENCH NF; GUERRA JC
    Rev Paul Med; 1957 Feb; 50(2):95-102. PubMed ID: 13442157
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of corticoids on urinary excretion of calcium, inorganic phosphates and hydroxyproline].
    Caniggia A; Gennari C; Bencini M; Palazzuoli V; Cesari L; Borrello G; Bissanti A
    Minerva Med; 1969 Jan; 60(6):165-70. PubMed ID: 5776764
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative studies on the effects of various angiolytics in angiopathy].
    KLEIBEL F
    Arztl Wochensch; 1958 Mar; 13(9-10):213-5. PubMed ID: 13533091
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary hydroxyproline excretion in orthopedic disease, with special reference to systemic bone disease and bone tumor (secondary report).
    Nakagawa M; Sugiura Y; Oshima T; Kajino G; Hirako H
    Nagoya J Med Sci; 1967 Mar; 29(4):345-67. PubMed ID: 6066099
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of vasoconstrictors used in local anesthetics in patients with diseases of the heart.
    SALMAN I; SCHWARTZ SP
    J Oral Surg (Chic); 1955 Jul; 13(3):209-13. PubMed ID: 14392539
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences with a new therapeutic agent for stenocardia].
    HANKE H
    Dtsch Med J; 1958 Aug; 9(8):432-3. PubMed ID: 13573972
    [No Abstract]   [Full Text] [Related]  

  • 29. Vasodilating measures in the treatment of peripheral vascular disease.
    KLASSON DH
    J Am Geriatr Soc; 1958 Jan; 6(1):33-8. PubMed ID: 13502011
    [No Abstract]   [Full Text] [Related]  

  • 30. [First observations on the therapeutic action of a new synthetic coronary vasokilator; 7-alpha-(acetoxyethane)-oxyflavone].
    TARTARA A; CORBETTA F
    Folia Cardiol; 1956 Oct; 15(5):539-49. PubMed ID: 13405097
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenesis and current treatment of shock studied from the aspects of the peripheral circulation and metabolism].
    Hayashi S; Ishiyama K; Tamakuma M; Koizumi S; Nakayama N
    Shujutsu; 1967 Dec; 21(12):1222-33. PubMed ID: 5598670
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of propranolol and indomethacin upon urinary hydroxyproline in hyperthyroid patients (author's transl)].
    Beylot M; Vincent M; Benzoni D; Bodson A; Riou JP; Mornex R
    Nouv Presse Med; 1982 Mar; 11(13):989-91. PubMed ID: 7070987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents?
    Cleland JG
    Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of hormone replacement therapy in bone resorption, in post-menopausal women].
    Villaseca P; Arteaga E; Campusano C; López JM; Rojas A; Nazar G; O'Brien A
    Rev Med Chil; 1996 Dec; 124(12):1439-46. PubMed ID: 9334477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hydroxyproline in generalized bone diseases].
    Czitober H; Raab W
    Dtsch Med J; 1970 Jun; 21(12):857-64. PubMed ID: 5512354
    [No Abstract]   [Full Text] [Related]  

  • 37. An evaluation of vasodilating measures in peripheral arterial insufficiency.
    STEIN ID
    Angiology; 1956 Oct; 7(5):432-5. PubMed ID: 13362993
    [No Abstract]   [Full Text] [Related]  

  • 38. [Local therapy of hay fever with vasoconstrictor drugs].
    ARBESSER K
    Monatsschr Ohrenheilkd Laryngorhinol; 1953; 87(4):274-8. PubMed ID: 13154243
    [No Abstract]   [Full Text] [Related]  

  • 39. [Can cerebral sclerosis, sequelae and peripheral vascular disorders be treated medically].
    SCHENK H
    Med Klin; 1957 Oct; 52(43):1885-7. PubMed ID: 13483040
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intra-arterial therapy in senile obliterating peripheral arterial diseases].
    CALDONAZZO C
    Athena; 1957 Mar; 23(3):93-8. PubMed ID: 13425953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.